Insulin degludec

Insulin degludec

Cat. No.: DIA-0243218

Size: 100 mg Size: 200 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 844439-96-9
Target Insulin Receptor
Product Description Insulin degludec is an ultra-long-acting form of insulin used for the research of hyperglycemia caused by type 1 and type 2 dabetes. Insulin degludec shows binding efficiency with an IC50 value of 19.59 nM for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes.
Format & Storage
Format Solid
Purity 99.94%
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
Solubility Overview 0.1 M HCL : 50 mg/mL H2O : 50 mg/mL
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top